Bank of America's list is based on the stocks’ relative-performance sensitivity to changes in the 10-year Treasury yield.

Needham analyst Mike Matson, who has a buy rating and $229 price target on ResMed, says the company will be helped by a Royal Philips recall.

The market needs clarity on the vaccine and the election.

Stock futures fall as Wall Street braces for the U.S. jobs report for March and coronavirus infections across the globe surpass 1 million; Tesla delivers its 'best ever' first-quarter performance; American Airlines drastically reduces both domestic and international flights.

Investors can’t fight this kind of selling, but they shouldn’t give up. Jim Cramer’s got a case for sitting tight. It will end.

Stocks finished higher Friday, as investors focus on Intel's earnings beat and news that the U.S. and China are close to finalizing parts of a phase one deal.

Jim Cramer's got the low-down on IPOs, the Fed, trade and more. Here's your game plan for next week's action.

Jim Cramer weighs in on Nucor, Wells Fargo, ResMed, Gulfport Energy, JD.com, Alibaba.

The company easily beats earnings expectations, but falls short on revenue.

People who are traveling by air are about to see a change in recent trends.

Beverage giant is rolling out a new taste in its efforts to attract and keep a key demographic.

You can find savings on everything from EVs to solar panels in the Inflation Reduction Act.